Central Pharmaceuticals Ltd

NEW
DHA:CENTRALPHL (Bangladesh)  
BDT 10.1 +0.20 (+2.02%) Aug 31
At Loss
P/B:
1.46
Market Cap:
BDT 1.21B ($ 9.87M)
Enterprise V:
BDT 1.48B ($ 12.05M)
Volume:
443.36K
Avg Vol (2M):
1.17M
Trade In:
Volume:
443.36K
At Loss

Central Pharmaceuticals Ltd’s share price is BDT10.1. Its GF Value is BDT12.14. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Central Pharmaceuticals Ltd stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: BDT10.1 GF Value Price/GF Value
Current BDT12.14 0.83
Next FY1 End BDT11.97 0.84
Next 12 Month BDT13.23 0.76
Next FY2 End BDT12.96 0.78
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing Central Pharmaceuticals Ltd's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The findings reveal that Central Pharmaceuticals Ltd's stock price shows no significant correlation with any of these four metrics.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies